Surrozen, Inc.
NASDAQ:SRZNBiotechnology
Healthcare
$30.67 -4.74%
-$1.14 today
- Market cap
- $229.33M
- Beta
- 0.51
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$31.29
52W Low $8.00High $35.00
Volume 0.09M
Average 0.11M
Balance Sheet
Inspect the capital base behind the business.
Assets
$98.73M
FY 2025 · Annual
+103.7% YoYLiabilities
$286.49M
FY 2025 · Annual
+310.2% YoYEquity
-$187.76M
FY 2025 · Annual
Balance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 33.09M | 24.69M | 36.04M | 34.57M | 89.25M |
| Short-term Investments | 68.76M | 51.15M | 0 | 0 | 0 |
| Net Receivables | 0 | 1.98M | 2.15M | 2.54M | 208K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 756K | 580K | 671K | 2.11M |
| Total Current Assets | 105.19M | 81.31M | 41.13M | 38.93M | 91.56M |
| Property, Plant & Equipment (Net) | 9.38M | 6.9M | 3.86M | 8.36M | 6.43M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 21.66M | 0 | 688K | 0 | 688K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 954K | 1.23M | 402K | 1.17M | 46K |
| Total Non-current Assets | 31.99M | 8.13M | 4.95M | 9.54M | 7.17M |
| Total Assets | 137.17M | 89.44M | 46.08M | 48.47M | 98.73M |
| Account Payables | 2.72M | 658K | 525K | 306K | 728K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 589K | 581K | 292K | 191K | 289K |
| Total Current Liabilities | 13.57M | 9.73M | 7.15M | 7.32M | 9.93M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 8.3M | 326K | 115K | 55.89M | 271.21M |
| Total Non-current Liabilities | 13.9M | 3.7M | 997K | 62.53M | 276.56M |
| Total Liabilities | 27.47M | 13.43M | 8.15M | 69.85M | 286.49M |
| Common Stock | 4K | 0 | 0 | 0 | 1K |
| Retained Earnings | (142.65M) | (178.65M) | (221.7M) | (285.26M) | (527.29M) |
| Accumulated OCI | (119K) | (241K) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 109.7M | 76M | 37.94M | (21.38M) | (187.76M) |
| Total Debt | 7.79M | 5.6M | 3.38M | 8.47M | 6.64M |
| Net Debt | (25.3M) | (19.09M) | (32.66M) | (26.1M) | (82.61M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $106.9M |
| Receivables | $5.0M |
| Other Current | $2.0M |
| Total Current Assets | $113.9M |
| PP&E (Net) | $6.0M |
| Long-term Investments | $688.0K |
| Other Non-current | $34.0K |
| Total Non-current Assets | $6.8M |
| Total Assets | $120.7M |
Analysis
Selected assets total $120.7M for Latest. The largest visible component is Cash & Equivalents at $106.9M, about 88.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| FWP | FWP filing | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| SC 13D/A | SC 13D/A filing | Nov 6, 2026 |
How much cash does SRZN have?
Surrozen, Inc. (SRZN) reported $89.25M in cash and equivalents in fiscal 2025.
How much debt does SRZN carry?
Surrozen, Inc. (SRZN) reported $6.64M of total debt, with net debt of -$82.61M.
Continue the stock analysis
Jump to another research area for this company.